Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 10Plasma cell 3Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Venous Thromboembolism 2Multiple Myeloma 2Pulmonary Embolism 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1

Interventions

Dexamethasone 262Lenalidomide 157daratumumab 135Bortezomib 113pomalidomide 89Calcium Dobesilate 86Cyclophosphamide 84carfilzomib 76Specimen Handling 46isatuximab 44fludarabine 43Biopsy 43belantamab mafodotin 41Magnetic Resonance Spectroscopy 38dexamethasone acetate 34dexamethasone 21-phosphate 34auricularum 33Melphalan 32talquetamab 29ixazomib 27iberdomide 27fludarabine phosphate 24selinexor 22elotuzumab 21Whole-Body Irradiation 17X-Rays 15venetoclax 14Mycophenolic Acid 13tocilizumab 12Stem Cell Transplantation 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
apixaban × Plasma cell × 1 year × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06474182 2025-09-25

ProApix

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Recruiting
32 enrolled
Plasma cell

Multiple Myeloma

NCT02066454 2025-08-13

MYELAXAT

University Hospital, Grenoble

Phase 3 Completed
108 enrolled
Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡